Amyotrophic Lateral Sclerosis (ALS) remains one of the most challenging neurodegenerative diseases to study and treat, with limited therapeutic options available for patients. To bridge the gap between basic research and clinical treatment, robust, reliable, and translational animal models are essential.

In this webinar, we will explore how our genetically engineered mouse models recapitulate key aspects of ALS pathology, providing researchers with powerful tools to investigate disease mechanisms, evaluate novel therapeutics, and accelerate drug development. 

Topics for this webinar include:

• A brief overview of ALS, its pathobiology, symptoms, progression, and the current state of research.

• In-depth exploration of various mouse models used to study ALS at GemPharmatech.

• An introduction to the application of ALS mouse models and study design to test drug efficacy.

Time:

Tuesday, August 26, 2025

8:00 AM PDT | 10:00 AM CDT | 11:00 AM EDT | 5:00 PM CEST